{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:09:17Z","timestamp":1774541357655,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.msard.2012.03.004","type":"journal-article","created":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T01:34:46Z","timestamp":1333503286000},"page":"131-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Reduced EDSS progression in multiple sclerosis patients treated with modafinil for three years or more compared to matched untreated subjects"],"prefix":"10.1016","volume":"1","author":[{"given":"Rashid H.","family":"Bibani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"Tench","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jithin","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Manouchehrinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Palace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cris S.","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2012.03.004_bib1","first-page":"4209","article-title":"Modafinil prevents glutamate cytotoxicity in cultured cortical neurons","volume":"9","author":"Antonelli","year":"1998","journal-title":"Neuro Report"},{"key":"10.1016\/j.msard.2012.03.004_bib2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4088\/JCP.v67n0406","article-title":"A systematic review of modafinil: potential clinical uses and mechanisms of action","volume":"67","author":"Balloon","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.msard.2012.03.004_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000232927","article-title":"Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients","volume":"62","author":"Brioschi","year":"2009","journal-title":"European Neurology"},{"key":"10.1016\/j.msard.2012.03.004_bib4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.msard.2012.03.004_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-2869.1999.00142.x","article-title":"Functional magnetic resonance imaging neuroactivation studies in normal subjects and subjects with the narcoleptic syndrome. Actions of modafinil","volume":"8","author":"Ellis","year":"1999","journal-title":"Journal of Sleep Research"},{"key":"10.1016\/j.msard.2012.03.004_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/jcbfm.2010.94","article-title":"Activation of the central histaminergic system is involved in hypoxia-induced stroke tolerance in adult mice","volume":"31","author":"Fan","year":"2011","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.msard.2012.03.004_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/syn.20111","article-title":"Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat","volume":"55","author":"Ferraro","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.msard.2012.03.004_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.RES.88.1.44","article-title":"Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries","volume":"88","author":"Fleming","year":"2001","journal-title":"Circulation Research"},{"key":"10.1016\/j.msard.2012.03.004_bib9","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1073\/pnas.0308185100","article-title":"Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors","volume":"101","author":"Granville","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.msard.2012.03.004_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00213-005-0013-8","article-title":"Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers","volume":"181","author":"Hou","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.msard.2012.03.004_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3940(03)00006-5","article-title":"Modafinil increases histamine release in the anterior hypothalamus of rats","volume":"339","author":"Ishizuka","year":"2003","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.msard.2012.03.004_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neulet.2010.08.005","article-title":"Modanifil activates the histaminergic system through the orexinergic neurons","volume":"48","author":"Ishizuka","year":"2010","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.msard.2012.03.004_bib13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s002210000370","article-title":"Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset","volume":"133","author":"Jenner","year":"2000","journal-title":"Experimental Brain Research"},{"key":"10.1016\/j.msard.2012.03.004_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2869.2008.00624.x","article-title":"Cerebral blood flow changes in man by wake-promoting drug, modafinil: a randomized double blind study","volume":"17","author":"Joo","year":"2008","journal-title":"Journal of Sleep Research"},{"key":"10.1016\/j.msard.2012.03.004_bib32","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00415-009-0152-7","article-title":"Modafinil effects in multiple sclerosis patients with fatigue","volume":"256","author":"Lange","year":"2009","journal-title":"Jornal of Neurology"},{"key":"10.1016\/j.msard.2012.03.004_bib15","doi-asserted-by":"crossref","first-page":"14128","DOI":"10.1073\/pnas.93.24.14128","article-title":"Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat","volume":"93","author":"Lin","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.msard.2012.03.004_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clineuro.2009.09.004","article-title":"Modafinil for multiple sclerosis fatigue: does it work","volume":"112","author":"Littleton","year":"2010","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"10.1016\/j.msard.2012.03.004_bib17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/jpet.106.106583","article-title":"Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro","volume":"319","author":"Madras","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.msard.2012.03.004_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.msard.2012.03.004_bib19","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","article-title":"Modafinil: a review of neurochemical actions and effects on cognition","volume":"33","author":"Minzenberg","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.msard.2012.03.004_bib20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.bcp.2007.01.002","article-title":"The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders","volume":"73","author":"Parmentier","year":"2007","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.msard.2012.03.004_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0006-8993(95)00711-X","article-title":"Effects of a vigilance-enhancing drug, modafinil, on rat brain metabolism: 2D COSY 1H NMR study","volume":"693","author":"Pi\u00e9rard","year":"1995","journal-title":"Brain Research"},{"key":"10.1016\/j.msard.2012.03.004_bib22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.msard.2012.03.004_bib23","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0090-9556(24)15146-X","article-title":"In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil","volume":"28","author":"Robertson","year":"2000","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.msard.2012.03.004_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00003088-200342020-00002","article-title":"Clinical pharmacokinetic profile of modafinil","volume":"42","author":"Robertson","year":"2003","journal-title":"Clinical Pharmacokinetics."},{"key":"10.1016\/j.msard.2012.03.004_bib25","doi-asserted-by":"crossref","first-page":"8620","DOI":"10.1523\/JNEUROSCI.20-22-08620.2000","article-title":"Hypothalamic arousal regions are activated during modafinil-induced wakefulness","volume":"20","author":"Scammell","year":"2000","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.msard.2012.03.004_bib26","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2174\/156802608784936728","article-title":"Histamine H3 antagonists as wake-promoting and pro-cognitive agents","volume":"8","author":"Stocking","year":"2008","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/j.msard.2012.03.004_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0304-3940(94)90639-4","article-title":"6-Hydroxy-dopamine treatment counteracts the reduction of cortical GABA release produced by the vigilance promoting drug modafinil in the awake freely moving guinea-pig","volume":"171","author":"Tanganelli","year":"1994","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.msard.2012.03.004_bib28","doi-asserted-by":"crossref","first-page":"10146","DOI":"10.1073\/pnas.0702291104","article-title":"Central histamine H3 receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNS","volume":"104","author":"Teuscher","year":"2007","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.msard.2012.03.004_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00230442","article-title":"Evidence for a preventive action of the vigilance-promoting drug modafinil against striatal ischemic injury induced by endothelin-1 in the rat","volume":"96","author":"Ueki","year":"1983","journal-title":"Experimental Brain Research"},{"key":"10.1016\/j.msard.2012.03.004_bib30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00008877-200609000-00011","article-title":"Philippens IHCHM. Neuroprotective effects of modafinil in a marmoset Parkinson model: behavioral and neurochemical aspects","volume":"17","author":"van Vliet","year":"2006","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.msard.2012.03.004_bib31","first-page":"301","article-title":"Neuroprotective mechanism of modafinil in Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine","volume":"25","author":"Xiao","year":"2004","journal-title":"Acta Pharmacologica Sinica"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034812000429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034812000429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:34:34Z","timestamp":1761899674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034812000429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S2211034812000429"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2012.03.004","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced EDSS progression in multiple sclerosis patients treated with modafinil for three years or more compared to matched untreated subjects","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2012.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}